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Abstract. Studies about silicon-substituted hydroxyapatites exhibit several shortcomings that leave 
unanswered questions regarding the properties and subsequent biological outcomes generated by this 
biomaterial. Firstly, samples characterization is often incomplete, meaning that phase purity on the 
pellet surface is not assured. In fact, ceramic materials used in literature that are claimed to be pure are 
actually polluted through second phase as superficial polymerized silicate. 
In this study, we have successfully synthesized a phase-pure silicon hydroxyapatite powder 
Ca10(PO4)5.5(SiO4)0.5(OH)1.5 (Si0.5HA) compressed this powder into pellets, sintered them, and 
evaluated the biological response of osteoblast cells (C3H10 line) seeded on the pellet surface. 
Besides, the solubility in aqueous media of HA and Si0.5HA pellets were determined through “static” 
experiments. These tests attempt to provide a comprehensive picture of the cellular response to the 
SiHA material, in order to determine the mechanism by which Si evokes the improved in vitro 
biological outcomes described in the literature. Results revealed first an equivalent solubility of 
Si0.5HA and HA pellets, and second that cells do not react favourably to the pure SiHA surface. 
Introduction 
Large bone defects resulting from trauma, cancer or malformations remain significant clinical 
problems. The use of autografts, allografts or currently available synthetic biomaterials is not really 
suitable for such cases. Among synthetic biomaterials, hydroxyapatite (HA, Ca10(PO4)6(OH)) 
ceramics have been used as synthetic bone graft substitutes for more than 30 years due to their 
bioactivity, osteoconductivity and biocompatibility with the human tissue. However, HA shows 
limited ability to stimulate the development of new bone tissue and has a very low rate of 
biodegradation. To further improve its biological properties and extend its clinical applications, ionic 
substitution into the HA crystal lattice has been tested. One of the most promising candidate appeared 
to be the silicate ion, which replaces phosphate in order to yield a silicated hydroxyapatite (SiHA, 
Ca10(PO4)6-y(SiO4)y(OH)2-y). 
Previous studies have shown beneficial biological properties of SiHA compared to HA, as rapid bone 
apposition and angiogenesis, faster bone maturity, and a higher solubility [1-5]. Unfortunately, a lot 
of questions remain regarding these results. Recent critical reviews highlighted the lack of 
experimental evidence which could explain the real effects of Si substitution on the biological activity 
of HA in biological environment [6-8]. 
 Materials and Methods 
Synthesis and pellets preparation. HA and Si0.5HA powders were prepared according to the 
protocol described in detail elsewhere [9]. Reagents ratio used to prepare the Si0.5HA powders were 
calculated according to the formula Ca10(PO4)5.5(SiO4)0.5(OH)1.5 and a constant molar ratio Ca/(P+Si) 
equals to 10/6. Precipitation was performed at 50°C, pH value 10.80 ± 0.05 for 24h. After filtration 
the as-synthesized powder was first dried at 80°C for 24h, then grinded manually with agate mortar 
and pestle. Before shaping and sintering HA and Si0.5HA were precalcined at 700°C for 1h and 900°C 
for 2h, respectively, in order to adjust their SBET surface area at about 25 m².g-1. Then, pellets were 
obtained by first a uniaxial pressing at 40 MPa of 450 mg of powder in a 12.6 mm diameter stainless 
steel die, followed by a cold isostatic pressing under 300 MPa. Pellets were sintered in a Super 
Kanthal furnace (Nabertherm LH30, Germany) in an air atmosphere at 1,150°C for 2h. The heating 
and cooling rates were fixed at 4°C/min. This sintering temperature was chosen to avoid the SiHA 
decomposition as well as to get an equivalent topography of the pellets surface. Finally, sintered 
pellets were mirror polished up to 1 µm diamond paste.  
Pellets physico-chemical characterization. Crystalline phases were identified on polished pellets 
by means of a θ/2θ X-ray diffractometer (XRD) Siemens D5000 using CuKα radiation at the 
operating conditions 40kV and 20mA. XRD patterns were collected over 2θ range of 24-41° at the 
step size of 0.03° and counting time of 13.5s per step in order to determine the phase composition. 
Fourier Transformed Infrared (FT-IR) measurements were carried out with the use of a Spectrometer 
Bruker HYPERION 2000 equipped for ATR mapping. The ATR objective is composed of an external 
crystal allowing the analysis of polished surface. The spectra were recorded over the range 450-4000 
cm-1 with a resolution of 2 cm-1. They are an average of 128 successive scans. Finally, spectra were 
normalized according to the classical procedure [10, 11]. The dissolution tests were performed using 
“static” conditions described in details previously [8, 12]. Tests were performed on HA and Si0.5HA 
pellets sintered at 1,200°C and 1,000°C for 2h, respectively. Their 5 points BET surface areas (SBET), 
determined using a Micrometric ASAP 2020 apparatus under nitrogen atmosphere, are equal to 0.4 
and 1.5 m2.g-1, respectively. The normalized mass loss NL (i;t) (in g.m-²), for i element and a 
dissolution time t, was calculated according to the concentrations in solution determined by 
Inductively Coupled Plasma Atomic Emission Spectrometry (ICP/AES) and the equation presented 
previously [12]. 
In vitro biological evaluation. The C3H10 cell line was used for all biological evaluations. Cells were 
cultured in Dulbecco’s Modified Eagle Medium supplemented with 2mM glutamine, 50U/mL 
penicillin, 50mg/mL streptomycin, 10% foetal calf serum (FCS), and the osteogenic differentiation 
factors ascorbic acid (50µg/mL) and β-glycerophosphate (10mM). Ceramic pellets were sterilized at 
180°C for 30 minutes prior to cell seeding. Pellets were placed in individual wells of a 24-well plate 
and cultured in 1 mL of medium. The plastic surface of culture wells without pellets was used as a 
positive control. Cells were trypsinized after passage 18 and seeded on the surface of each pellet and 
in control wells at a density of 5,000 cells.cm-2. Cultures were then incubated at 37°C with 5% CO2 
and cell media was changed every 2-3 days. All reagents were purchased from Sigma, Saint-Quentin 
Fallavier, France. The growth of cell populations was determined using the MTT Viability Test 
[3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide - Sigma], which was conducted after 
1, 3, 6, and 8 days of culture. This assay is based on the enzymatic reduction of the MTT reagent 
linked to the production of purple color which is quantified by absorbance measurement using a 
spectrophotometer. For each measurement, cells were rinsed twice with DMEM without serum and 
0.1% BSA before incubation with MTT dye at a concentration of 1:10 for 4 hours. Cells were then 
incubated for 45 minutes, the last 5 of which, under mild agitation. Using a Thermo Multiskan 
Spectrum spectrophotometer, the absorbance at 570nm was measured. The cell proliferation was 
monitored through the incorporation of the pyrimidine analogue 5-bromo-2’-deoxyuridine (BrdU) 
into DNA, which can be detected by immunoassay (Roche Applied Science). On the third and sixth 
 days of culture, the cells were incubated with the BrdU labeling solution at a concentration of 1:10 in 
culture medium for 2 hours at 37°C. After denaturation, labeling with an anti-BrdU antibody 
conjugated with peroxidase, and washing, the absorbance was measured at 370 nm with a reference 
reading at 492 nm (Thermo Multiskan Spectrum spectrophotometer). All proliferation absorbance 
readings were normalized to the absorbance for that time point obtained by the cell growth assay to 
effectively determine the ratio of proliferating cells in each condition. Finally, in order to prepare 
samples for SEM imaging, pellets were fixed with 2.5% glutaraldehyde for 20 minutes, rinsed with 
Phosphate Buffered Saline (PBS), and then dehydrated in successive acetone baths ranging from 30% 
to 99%, lasting 10 minutes each. Just prior to imaging, pellets were coated with a thin gold layer by 
the low vacuum sputter coating method to create an electrically-conductive surface. 
Results and Discussions 
X-ray diffraction patterns of both HA and Si0.5HA pellets (Figure 1) exhibit only the characteristic 
diffraction lines of the hydroxyapatite HA (PDF 09-432). IR spectra of HA and Si0.5HA pellets 
surface (Figure 2) show the vibration bands of phosphate groups at 475 (υ2), 564 (υ4), 600 (υ4), 962 
(υ1), 1024 (υ3) and 1087 (υ3) cm-1, and the ones of hydroxide groups at 628 (υL) and (υS) 3570 cm-1 
that are characteristic of calcium hydroxyapatite. However, the intensity of the stretching and 
librational modes of the hydroxide groups are lower for SiHA than for HA, as already described [9]. 
Besides, SiHA spectrum displays bands and shoulders (sh) related to the incorporation of Si into the 
hydroxyapatite structure: 492 (sh), 504, 525, 750, 835 (sh), 889, 981 (sh) and 1000 (sh) cm-1 [9]. On 
the other hand, no IR band due to silica (e.g. 683, 798, 870 cm-1) or tricalcium phosphate (e.g. 495, 
567, 945, 1013, 1025 or 1055 cm-1 [13]) is detected. The surface of the HA and Si0.5HA pellets are 
monophasic and free of crystalline or amorphous second phases. The sintering heat-treatment at 
1150°C for 2h does not decompose the SiHA phase and allows getting equivalent surface topography 
(Figure 3).  
 
Figure 1. XRD patterns of HA and Si0.5HA 
sintered and polished pellets. 
 
Figure 2. FTIR spectra of HA and Si0.5HA 
sintered and polished pellets. 
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Figure 3. SEM micrographs of the surface of (a) HA and (b) Si0.5HA polished pellets before 
biological evaluation. 
Ions concentrations measured at the equilibrium (t = 144h) after dissolution in HNO3 solutions 
(5.10-3 and 0.1M) of powders and pellets are not significantly different (see Table 1). It confirms that 
these pulverulent or sintered samples have a similar solubility behavior. Yet, it was determined that 
HA and Si0.5HA powders exhibit an equivalent solubility product range between 138 ≥ pKS ≥ 123 [8]. 
Table 1. Ca, P and Si concentrations at the equilibrium (144h) and related normalized mass loss (NL) 
of HA and Si0.5HA powders and pellets in HNO3 solution at 0.1M 
 m V [Ca] [P ]  [Si]  NL(Ca)  NL(P)  NL(Si)  
  / g / L  /mol.L-1  / mol.L-1  / mol.L-1 / mg.m-2 / mg.m-2 / mg.m-2 
Powder HA 0.20 0.020 7.25 10-2 4.35 10-2 - 979.0 981.4 - 
Pellet HA  0.25 0.010 7.50 10-2 4.48 10-2 - 756.2 753.0 - 
Powder SiHA 0.21 0.020 6.96 10-2 4.16 10-2 3.26 10-3 273.1 269.5 226.7 
Pellet SiHA  0.23 0.010 7.36 10-2 3.92 10-2 3.90 10-3 199.6 193.3 211.6 
Cell growth and cell proliferation are presented on Figures 4 and 5 respectively. Figure 4 indicate 
that pure Si0.5HA pellet surface does not foster prolonged cell growth conversely to the HA one. A 
two-way ANOVA with repeated measures confirms that both time and the composition of the 
substrate affect cell growth. Cell proliferation after three days is significantly greater on HA than on 
pure SiHA. Though the ratio of normalized proliferating cells (Figure 5b) is equivalent for both 
conditions at day 6, too few cells are present on the pure Si0.5HA pellets for the cell growth to catch up 
with HA (Figure 5a). The SiHA ability to promote cell proliferation in early cultures falls short of the 
HA. SEM images show that HA surface is entirely covered by ECM proteins while the substrate 
porosity is still visible on pure Si0.5HA (Figure 6). It indicates that cells seeded on this surface did not 
deposit matrix. Moreover, cells seeded on HA surface adhered, and broadly spread out to cover the 
surface. In contrast, cells on the pure Si0.5HA pellets remain balled up and formed only few direct 
contact sites with the substrate. 
Osteoblast cells clearly do not react favorably to the pure Si0.5HA phase. This phenomenon does not 
arise from the non-therapeutic release of silicon or calcium within the media since HA and Si0.5HA 
show an equivalent and very low solubility product. Likewise, topographical effects are not relevant. 
The surface chemistry and more especially the Si-OH groups at the Si0.5HA surface could modify cell 
attachment, movement, proliferation or differentiation through conformational changes in 
extracellular matrix proteins. 
 
  
Figure 4. Cell growth on HA and Si0.5HA 
polished pellets after 1, 3, 6, and 8 days of 
culture. *P < 0.05 
 
Figure 5. Cell proliferation on HA and Si0.5HA 
pellets (a) BrDU absorbance, (b) BrDU 




Figure 6. SEM micrographs of (a) HA and (b) Si0.5HA pellet surfaces after 3 days of culture with 
C3H10 cells. 
Conclusion 
This study reveals that cells seeded on pure Si0.5HA (Ca10(PO4)5.5(SiO4)0.5(OH)1.5) pellets do not 
grow, and proliferate less than those on HA substrate after 3 days of culture. It seems that many cells 
simultaneously undergo cell death. The positive biological outcomes of silicon-substituted 
hydroxyapatites claimed by literature are not confirmed for pure silicon-substituted hydroxyapatite 
phase. Surface chemistry of the Si0.5HA ceramic seems disturbing the deposition of ECM, and 
affecting the ability of the osteoblast cells to attach, to move and more generally to survive. 
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